Chenlu Zhu

Dr. Chenlu Zhu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CZChenlu Zhu
Chenlu Zhu
XLXuejiao Liu
Xuejiao Liu
Alzheimer’s disease (AD) is a central nervous system degenerative disease with insidious onset and gradual development caused by selective and progressive loss of neurons. The 5xFAD mouse is a relatively mature disease model of AD. However, the behavioral research on 5xFAD female mouse is more focused on the changes of late memory function, and the exploration of its early behavioral and pathological changes is still incomplete. This research aims to explore the changes in memory function, emotional function (including anxiety and depression), motor ability, amyloid plaques, glial cell response and neurogenesis in the hippocampus of female 5xFAD mice in the early stage, laying a foundation for a comprehensive exploration of the disease mechanism of AD. The results of this study found that early 4-month-old female 5xFAD mice mainly showed a decline in memory function without other dysfunction. Accompanied by a large amount of amyloid protein plaques deposited in the hippocampus, it induced the response of microglia and astrocytes, and neurogenesis decreased significantly with age, especially in early female 5xFAD mice, which resulted in a decrease in the number of new neurons. This may be an important reason for the decline in memory function of female 5xFAD mice in the early stage.

29 November 2024 in Research Square
Verified
Preprint
Open access
PDF file
CZChenlu Zhu
Chenlu Zhu
XLXuejiao Liu
Xuejiao Liu
Alzheimer's disease (AD) is a central nervous system degenerative disease with insidious onset and gradual development caused by selective and progressive loss of neurons. The 5xFAD mouse is a relatively mature disease model of AD. However, the behavioral research on 5xFAD female mouse is more focused on the changes of late memory function, and the exploration of its early behavioral and pathological changes is still incomplete. This research aims to explore the changes in memory function, emotional function (including anxiety and depression), motor ability, amyloid plaques, glial cell response and neurogenesis in the hippocampus of female 5xFAD mice in the early stage, laying a foundation for a comprehensive exploration of the disease mechanism of AD. The results of this study found that early 4-month-old female 5xFAD mice mainly showed a decline in memory function without other dysfunction. Accompanied by a large amount of amyloid protein plaques deposited in the hippocampus, it induced the response of microglia and astrocytes, and neurogenesis decreased significantly with age, especially in early female 5xFAD mice, which resulted in a decrease in the number of new neurons. This may be an important reason for the decline in memory function of female 5xFAD mice in the early stage.

29 October 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JLJing Lu
Jing Lu
CZChenlu Zhu
Chenlu Zhu
Background: Central sensitization is the core pathological mechanism driving the occurrence and chronification of chronic migraine (CM). Transient Receptor Potential Canonical 5 (TRPC5) channel is critically involved in the modulation of multiple pain disorders and central sensitization. However, the specific regulatory role and precise molecular mechanism of TRPC5 in the progression of acute and chronic migraine remain unclear. This study aimed to explore the potential function of TRPC5 and its downstream signaling cascade in nitroglycerin (NTG)-induced migraine-like central sensitization, so as to provide novel preclinical evidence for migraine pathogenesis and targeted intervention. Methods: A repetitive NTG intraperitoneal injection protocol was applied to establish a mouse model mimicking acute migraine nociceptive responses and chronic migraine central sensitization. Migraine-like behavioral phenotypes, including mechanical allodynia, thermal hyperalgesia and light-aversive behavior, were evaluated at both acute and chronic modeling stages. qRT-PCR and Western blot were performed to detect TRPC5 mRNA and protein expression in the primary somatosensory (SSP) cortex. Immunofluorescence staining was used to verify the neuronal localization of upregulated TRPC5 and assess the activation status of cortical neurons and microglia. Pharmacological interventions with TRPC5 selective antagonist AC1903 and phosphoinositide 3-kinase-protein kinase B (PI3K-Akt) inhibitor LY294002 were applied to validate the regulatory relationship among TRPC5, PI3K-Akt signaling and purinergic receptor P2X7/interleukin-1 beta (P2X7R/IL-1β)inflammatory axis. Results: Repeated NTG challenge induced robust migraine-like behaviors, prominent neuronal hyperactivation and sustained central sensitization within the SSP cortex. TRPC5 mRNA and protein were markedly increased mainly in SSP cortical neurons. NTG also triggered microglial overactivation and upregulated P2X7R and IL-1β. AC1903-mediated TRPC5 inhibition alleviated acute and chronic migraine-like phenotypes, blunted neuronal and microglial activation, suppressed PI3K-Akt overactivation and reduced P2X7R/IL-1β expression. LY294002 blockade of PI3K-Akt recapitulated these protective effects, attenuating sensory hypersensitivity and neuroinflammation. Conclusion: TRPC5 mediates NTG-induced migraine central sensitization. Neuronal TRPC5 upregulation activates PI3K-Akt signaling, inducing neuronal hyperexcitability, microglial overactivation and P2X7R/IL-1β neuroinflammation. This TRPC5-dependent axis controls acute nociception and chronic migraine progression. Our findings uncover neuron-microglia crosstalk and support TRPC5 as a preclinical therapeutic target for migraine.

30 March 2025 in Brain Conflux
Verified
Journal Article
Open access
PDF file
CZChenlu Zhu
Chenlu Zhu
Alzheimer's disease (AD) is increasingly impacting the aging global population, with its prevalence and mortality rates rising steadily. This trend severely affects the quality of life and intensifies the economic strain on both families and society. Despite ongoing research, effective treatments remain elusive. However, enhancing neurogenesis in the hippocampal dentate gyrus (DG) to promote the formation of new neurons and replace those lost in AD patients' hippocampus holds promise as a potential strategy to improve cognitive and memory functions, offering hope for delaying or even treating the disease.